Invention Grant
- Patent Title: Compounds which modulate the CB2 receptor
- Patent Title (中): 调节CB2受体的化合物
-
Application No.: US12741260Application Date: 2008-10-30
-
Publication No.: US08546563B2Publication Date: 2013-10-01
- Inventor: Angela Berry , Doris Riether , Renee M. Zindell , Nigel James Blumire
- Applicant: Angela Berry , Doris Riether , Renee M. Zindell , Nigel James Blumire
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- International Application: PCT/US2008/081680 WO 20081030
- International Announcement: WO2009/061652 WO 20090514
- Main IPC: C07D205/00
- IPC: C07D205/00 ; C07D413/12 ; C07D213/00 ; C07D277/82 ; C07D231/10 ; C07D285/08 ; C07D261/14 ; C07D249/14 ; A61K31/535 ; A61K31/445 ; A61K31/425 ; A61K31/41 ; A61K31/42 ; A61K31/44
Abstract:
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20100331304A1 Compounds Which Modulate The CB2 Receptor Public/Granted day:2010-12-30
Information query
